Miplyffa is the first drug approved for treating associated neurological symptoms in adults and children 2 years and older. HealthDay News — The U.S. Food and Drug Administration has approved Miplyffa ...
Immunocompromised patients who had rhinovirus and parainfluenza who received IV immunoglobulin had a significant decrease in hospital length of stay. Intravenous immunoglobulin (IVIG) was associated ...